entinostat has been researched along with Carcinoma, Epidermoid in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cutaneous squamous cell carcinomas are a common form of highly mutated keratinocyte skin cancers that are of particular concern in immunocompromised patients." | 1.51 | Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model. ( Cole, PA; Dinkova-Kostova, AT; Eroglu, A; Fahey, JW; Holtzclaw, WD; Kalin, JH; Leigh, I; Liu, H; Proby, CM, 2019) |
| "Esophageal squamous cell carcinoma (ESCC) is a malignant tumor with low survival rate, so new therapies are urgently needed." | 1.51 | Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway. ( Cui, Y; Guan, F; Huang, T; Li, P; Liu, H; Liu, T; Ma, S; Wang, Y; Xu, L; Zang, X; Zhang, Y; Zhou, J; Zhou, X, 2019) |
| "Esophageal cancers are highly aggressive tumors with poor prognosis despite some recent advances in surgical and radiochemotherapy treatment options." | 1.42 | Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine. ( Ahrens, TD; Boerries, M; Busch, H; Follo, M; Hembach, S; Hoeppner, J; Hopt, UT; Lassmann, S; Ostendorp, J; Timme, S; Werner, M, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Krieger, V | 1 |
| Hamacher, A | 1 |
| Cao, F | 1 |
| Stenzel, K | 1 |
| Gertzen, CGW | 1 |
| Schäker-Hübner, L | 1 |
| Kurz, T | 1 |
| Gohlke, H | 1 |
| Dekker, FJ | 1 |
| Kassack, MU | 1 |
| Hansen, FK | 1 |
| Marques, AEM | 1 |
| do Nascimento Filho, CHV | 1 |
| Marinho Bezerra, TM | 1 |
| Guerra, ENS | 1 |
| Castilho, RM | 1 |
| Squarize, CH | 1 |
| Huang, XP | 1 |
| Li, X | 1 |
| Situ, MY | 1 |
| Huang, LY | 1 |
| Wang, JY | 1 |
| He, TC | 1 |
| Yan, QH | 1 |
| Xie, XY | 1 |
| Zhang, YJ | 1 |
| Gao, YH | 1 |
| Li, YH | 1 |
| Rong, TH | 1 |
| Wang, MR | 1 |
| Cai, QQ | 1 |
| Fu, JH | 1 |
| Kalin, JH | 1 |
| Eroglu, A | 1 |
| Liu, H | 2 |
| Holtzclaw, WD | 1 |
| Leigh, I | 1 |
| Proby, CM | 1 |
| Fahey, JW | 1 |
| Cole, PA | 1 |
| Dinkova-Kostova, AT | 1 |
| Ma, S | 1 |
| Liu, T | 1 |
| Xu, L | 1 |
| Wang, Y | 2 |
| Zhou, J | 1 |
| Huang, T | 1 |
| Li, P | 1 |
| Zhang, Y | 1 |
| Zhou, X | 1 |
| Cui, Y | 1 |
| Zang, X | 1 |
| Guan, F | 1 |
| Ahrens, TD | 1 |
| Timme, S | 1 |
| Hoeppner, J | 1 |
| Ostendorp, J | 1 |
| Hembach, S | 1 |
| Follo, M | 1 |
| Hopt, UT | 1 |
| Werner, M | 1 |
| Busch, H | 1 |
| Boerries, M | 1 |
| Lassmann, S | 1 |
6 other studies available for entinostat and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Synthesis of Peptoid-Based Class I-Selective Histone Deacetylase Inhibitors with Chemosensitizing Properties.
Topics: Aniline Compounds; Antineoplastic Agents; Apoptosis; Benzamides; Carcinoma, Squamous Cell; Cell Prol | 2019 |
Entinostat is a novel therapeutic agent to treat oral squamous cell carcinoma.
Topics: Apoptosis; Benzamides; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; H | 2020 |
Entinostat reverses cisplatin resistance in esophageal squamous cell carcinoma via down-regulation of multidrug resistance gene 1.
Topics: Adult; Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transport | 2018 |
Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model.
Topics: Administration, Topical; Animals; Benzamides; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proli | 2019 |
Histone deacetylases inhibitor MS-275 suppresses human esophageal squamous cell carcinoma cell growth and progression via the PI3K/Akt/mTOR pathway.
Topics: Animals; Antineoplastic Agents; Apoptosis; Benzamides; Carcinoma, Squamous Cell; Cell Cycle Checkpoi | 2019 |
Selective inhibition of esophageal cancer cells by combination of HDAC inhibitors and Azacytidine.
Topics: Acetylation; Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azacitidine; | 2015 |